Key Stock Data. 1  P/E Ratio (TTM) N/A. 2  EPS (TTM) $-1.48. 3  Market Cap $10.91 M. 4  Shares Outstanding 41.35 M. 5  Public Float 18.48 M. 6  Yield ARGS has not issued dividends in more than 1 year. 7  Latest Dividend N/A. 8  Ex-Dividend Date N/A.
The turbinates are paired structures that are located within the nasal cavity. Hypertrophy refers to an increase in the size of an organ or tissue; consequently, turbinate hypertrophy is the enlargement of the turbinates. Hypertrophy can occur and result in total obstruction of the nasal airways.
The first step in treating inferior turbinate hypertrophy is taking medications that reduce the inflammation in the nose. Nasal Steroid Sprays (Nasacort, Flonase, etc.) and Antihistamine Sprays (Astepro, Patanase, etc.). These sprays are great first-line medications with consistent benefit and little side effects.